Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The epidemic of Ebola virus disease has spread at an alarming rate despite containment efforts. As a result, unprecedented large-scale international response efforts have been made in an attempt to gain control of the outbreak and reduce transmission. Several international consortia have been formed in a remarkable worldwide collaborative effort to expedite trials of two candidate Ebola virus vaccines: cAd3-EBOZ and rVSV-EBOV. In parallel, both vaccines are being manufactured in large amounts to enable future rapid deployment for management of the crisis.

Original publication

DOI

10.1016/S1473-3099(14)71071-0

Type

Journal article

Journal

Lancet Infect Dis

Publication Date

03/2015

Volume

15

Pages

356 - 359

Keywords

Clinical Trials as Topic, Disease Outbreaks, Ebola Vaccines, Ebolavirus, Hemorrhagic Fever, Ebola, Humans, International Cooperation